Doctor checking client

Moving Medicine Forward

We work with experts across the industry to ensure our clinical trial design and execution is conducted with the utmost respect for patient safety and wellbeing.

We understand the decision to participate in any clinical research is not made lightly and are incredibly grateful to those patients and families who choose to do so. We are also thankful for the dedicated staff and clinicians at the hospitals and clinics that help conduct and support our research.

Current Trials

HOPE-3: Phase 3 Clinical Trial

A Study of deramiocel (CAP-1002) in Ambulatory and Non-Ambulatory Patients with Duchenne Muscular Dystrophy


Learn more about Capricor’s current ongoing Phase 3 clinical trial, HOPE-3. Search for study ID number: NCT05126758 at

HOPE-3 logo
View Clinical Trial Info

HOPE-2: Phase 2 Open Label Extension

Active, not recruiting

Search for study ID number: NCT04428476 at

View Clinical Trial Info


For more information on enrollment in our current clinical trials, please contact us or visit

Contact Us

The safety and efficacy of the investigational use of these products have not been determined. There is no guarantee that the investigational use listed will be filed with and/or approved for marketing by a regulatory agency.